Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1445-1451

  Aparicio, Thomas ^a   Kermorgant, Stéphanie ^a   Dessirier, Valérie ^a   Lewin, Miguel J M ^a   Lehy, Thérèse ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER CELL CULTURE; CANCER INVASION; CANCER PREVENTION; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLON CANCER; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; COLLAGENASES; COLONIC NEOPLASMS; FEMALE; GELATINASES; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PERITONEAL NEOPLASMS; PHENYLALANINE; RATS; THIOPHENES; TUMOR CELLS, CULTURED;

EID: 0032868752     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1445     Document Type: Article

References (28)

1. Sant, M., Capocaccia, R., Verdecchia, A., Gatta, G., Micheli, A., Mariotto, A., Hakulinen, T. and Berrino, F. (1995) Comparisons of colon-cancer survival among European countries: The Eurocare Study. Int. J. Cancer, 63, 43-48.
2. Liotta, L.A. and Kohn, E. (1990) Cancer invasion and metastases. J. Am. Med. Assoc., 263, 1123-1126.
3. Hewitt, R.E., Leach, I.H., Powe, D.G., Clark, I.M., Cawston, T. and Turner, D.R. (1991) Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int. J. Cancer, 49, 666-672.
4. Levy, A.T., Coice, V., Sobel, M.E., Garbisa, S., Grigioni, W.F., Liotta, L.A. and Stetler-Stevenson, S. (1991) Increased expression of the Mr 72,000 type IV collagenase in human colonie adenocarcinoma. Cancer Res., 51, 439-444.
5. Newell, K.J., Witty, J.P., Rodgers, W.H. and Matrisian, L.M. (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol. Carcinog., 10, 199-206.
6. Witty, J.P., McDonnell, S., Newell, K.J., Ness, E., Dickson, R., Barter, J., Sale, M., McCann, P., Moore, J., Cole, A. and Hawkins, M.J. (1994) Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res., 54, 4805-4812.
7. Okada, A., Bellocq, J.P., Rouyer, N., Chenard, M.P., Rio, M.C., Chambon, P. and Basset, P. (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl Acad. Sci. USA, 92, 2730-2734.
8. Zeng, Z.S. and Guillem, J.G. (1995) Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br. J. Cancer, 72, 575-582.
9. Mori, M., Barnard, G.F., Mimori, K., Ueo, H., Akiyoshi, T. and Sugimachi, K. (1995) Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer, 75, 1516-1519.
10. Ohtani, H., Motohashi, H., Sato, H., Seiki, M. and Nagura, H. (1996) Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int. J. Cancer, 68, 565-570.
11. Takeuchi, N., Ichikawa, Y., Ishikawa, T., Momiyama, N., Hasegawa, S., Nagashima, Y., Miyazaki, K., Koshikawa, N., Mitsuhashi, M. and Shimada, H. (1998) Matrilysin gene expression in sporadic and familial colorectal adenomas. Mol. Carcinog., 19, 225-229.
12. Wang, X., Fu, X., Brown, P.D., Crimmin, M.J. and Hoffman, R.M. (1994) Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res., 54, 4726-4728.
13. Watson, S.A., Morris, T.M., Robinson, G., Crimmin, M.J., Brown, P.D. and Hardcastle, J.D. (1995) Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res., 55, 3629-3633.
14. Watson, S.A., Morris, T.M., Parsons, S.L., Steele, R.J.C. and Brown, P.D. (1996) Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model. Br. J. Cancer, 74, 1354-1358.
15. Zervos, E.E., Norman, J.G., Gower, W.R., Franz, M.G. and Rosemurgy, A.S. (1997) Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo. J. Surg. Res., 69, 367-371.
16. Jeannin, J.F., Lagadec, P., Pelletier, H., Reisser, D., Olsson, N.O., Chihara, G. and Martin, F. (1988) Regression induced by lentinan, of peritoneal carcinomatoses in a model of colon cancer in rat. Int. J. Immunopharmacol., 10, 855-861.
17. Ruszniewski, P., Lehy, T., Reyl-desmars, F., Leroux, S. and Lewin, M.J.M. (1993) Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats. Regul. Pept., 43, 141-147.
18. Gouyon, B., Reyl-Desmars, F., Le Romancer, M., Pigeon, C., Lewin, M.J.M. and Lehy, T. (1995) In vivo effect of somatostatin analogue, lanreotide and/or GRP antagonist, BIM 26226, on the growth of colon cancer peritoneal carcinomatosis in the rat. Int. J. Oncol., 7, 1167-1173.
19. Martin, F., Caignard, A., Jeannin, J.F., Leclerc, A. and Martin, M. (1983) Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer, 32, 623-627.
20. Giambernardi, T.A. and Grant, G. (1998) Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol., 16, 483-496.
21. Dempsey, P.J., Meise, K.S., Yoshitake, Y., Nishikawa, K. and Coffey, R.J. (1997) Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor. J. Cell Biol., 138, 747-758.
22. Davies, B., Brown, P.D., East, N., Crimmin, M.J. and Balkwill, F.R. (1993) A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing ovarian carcinoma xenografts. Cancer Res., 53, 2087-2091.
23. Low, J.A., Johnson, M.D., Bone, E.A. and Dickson, R.B. (1996) The matrix metalloproteinase inhibitor Batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin. Cancer Res., 2, 1207-1214.
24. Eccles, S.A., Box, G.M., Court, W.J., Bone, E.A., Thomas, W. and Brown, P.D. (1996) Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor Batimastat (BB-94). Canrer Res., 56, 2815-2822.
25. Wojtowicz-Praga, S., Low, J., Marshall, J., Ness, E., Dickson, R., Barter, J., Sale, M., McCann, P., Moore, J., Cole, A. and Hawkins, M.J. (1996) Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Invest. New Drugs, 14, 193-202.
26. Wilks, J.W., Mattern, S.J., Dekoning, T.F., Poorman, R.A. and Vera, E.E. (1998) Murine colon 38 tumor models for evaluation of a matrix metalloproteinase inhibitor (MMP1). Proc. Am. Assoc. Cancer Res., 39, 296 (Abstract 2016).
27. Anderson, I.C., Shipp, M.A., Docherty, A.J.P. and Teicher, B.A. (1996) Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res., 56, 715-718.
28. Denis, L.J. and Verweij, J. (1997) Matrix metalloproteinase inhibitors: Present achievements and future prospects. Invest. New Drugs, 15, 175-185.